Register Now!Registration Fee:  $59.00 - Fees are non-refundable

When:

Saturday, October 22, 2016 

Target Audience:

Physicians and other clinicians who care for people with CRPS. 

Add to Calendar

Where:

Aloft Chicago O'Hare Hotel 
9700 Balmoral Avenue
Rosemont, IL 60018
  

 
Driving Directions 

Additional Information:
  • Reservations: Call 844.247.3233,  or Book a Room online. 

Airport: O'Hare - ORD 

Contact:

Jim Broatch
877.662.7737 
jwbroatch@rsds.org 

Is Ketamine the Best Treatment for your Patients with CRPS today?
How do you know?

Join other physicians and nurses on October 22, 2016 in Chicago for a day-long discussion of Ketamine Treatment for CRPS: The State of the Art and the Science to hear and debate the latest evidence and options for future research on this hypothetical life-altering therapy. We will review literature on outcomes, discuss three current protocols and adverse events profiles, identify other indications for ketamine infusions, and talk about battlefield use and the potential for abuse.

Physicians and nurses in the chronic pain field know how difficult chronic, refractory complex regional pain syndrome (CRPS) can be to treat. More than 150 years since it was initially identified, we are still looking for effective treatments for this horribly painful condition. In the last few years, pain management physicians have begun using IV ketamine to treat people with CRPS.  Although some studies show promising results, protocols vary widely and safety and efficacy are unproven. In fact, there are 18 peer-reviewed journal articles in PubMed on using IV Ketamine for CRPS and the outcomes are inconclusive. The only thing we know for sure is that we need more studies, more research, and targeted discussions. People who suffer from CRPS are depending on it.

4 Reasons to Attend this Conference:

  • Learn how to evaluate the current treatment protocols and their adverse event profiles.
  • Discuss other conditions that might benefit from ketamine infusions.
  • Contribute to the development of a consensus protocol for CRPS-Ketamine treatment.
  • Physicians earn 6.25 CME credits:
    Credit Statement:  Amedco designates this live activity for a maximum of 6.25 AMA PRA Cateogry 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    Approval Statement:  This activity has been planned and implemented in accordance with the accreditation requirement and policies of the Accreditation Council for Continuing Medical Education (ACCMA) through the joint providership of the Amedco and RSDSA. Amedco is accredited by the ACCME to provide continuing medical education for physicians.
  • Nurses earn maximum of 6.25 contact hours
    Amedco is accredited as a provider of continuing nursing educatin by the American Nurses Credentialing Center's Commission on accreditation.  This course is co-provided by Amedco and RSDSA. Maximum of 6.25 contact hours. 

View the Conference Agenda Now!

If you are utilizing IV ketamine to treat CRPS and have not yet completed our IV Ketamine Infusion for CRPS survey, please click here.


Saturday's conference is for physicians and nurses only. However there will be a special half-day program for individuals with CRPS/Caregivers on Sunday, October 23rd. The fee is $25.00. To register please click here. or for further information please email Jim Broatch at info@rsds.org or call 877.662.7737.


Conference Chairs:

  • Gary J. Bennett, PhD, Canada Senior Research Chair, Anesthesia and faculty of Dentistry, McGill University, Montreal, Quebec Canada
  • R. Norman Harden, MD, Chair of the RSDSA Research Committee, professor emeritus, Northwestern University, Department of Physical Medicine and Rehabilitation, Department of Therapy and Movement Science, Chicago, Illinois.

In addition to our expert conference chairs, you will hear from researchers and physicians who have used ketamine extensively to treat CRPS and other conditions, including:

  • Carl J. Bonnett, MD, Founder and Medical Director, Klarisana, San Antonio, Texas
  • Justin Bose, DO, Double boarded in Anesthesiology and Pain Medicine, San Antonio, Texas
  • Ricardo Cruciani, MD, PhD, Chair of the Department of Neurology at Drexel University College of Medicine, Philadelphia, Pennsylvania
  • Samyadev Datta, MD, FRCA, Board certified anesthesiologist, Center for Pain Management, Hackensack, NJ.
  • Philip Getson, DO, Family Practitioner in Marlton, New Jersey
  • Ashaf Hanna, MD, Board certified in both Anesthesiology and Pain Management, Clearwater, Florida
  • Ronald E. Harbut, MD, Anesthesiology and Pain Management specialist, Hot Spring, Arkansas.
  • Jay Joshi, MD, CEO and Medical Director of the National Pain Centers LLC. Board certified anesthesiologist and fellowship trained Interventional Spine and Pain Management physician,  Vernon Hills, Illinois
  • Edward Pang, DO, MS, VA Greater LA Healthcare System, Los Angeles, California
  • Joshua Prager, MD, Director of California Pain Medicine Center at UCLA Medical Center, Los Angeles, California
  • Jijun Xu, MD, PhD, Anesthesiology and Pain Management specialist, Cleveland Clinic, Cleveland, Ohio